TipRanks
Go Ultimate55% OFF

Compare Terveystalo Oy (4TS) vs. Competitors

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
DE:4TSTerveystalo OyEUR 5.96EUR 762.89M13.32-34.58%―Unlock the DE:4TS analyst price target with TipRanks PremiumDE:4TSUnlock the DE:4TS top-analyst price target with TipRanks Premium
TTALFTerveystalo Oy$6.83$852.01M13.32-47.26%―Unlock the TTALF analyst price target with TipRanks PremiumDE:4TS vs TTALFUnlock the TTALF top-analyst price target with TipRanks Premium
SEMHFSiemens Healthineers AG$47.69$53.45B21.66-17.42%Moderate BuyUnlock the SEMHF analyst price target with TipRanks PremiumDE:4TS vs SEMHFUnlock the SEMHF top-analyst price target with TipRanks Premium
ADUSAddus Homecare$125.54$2.34B22.106.45%Moderate BuyUnlock the ADUS analyst price target with TipRanks PremiumDE:4TS vs ADUSUnlock the ADUS top-analyst price target with TipRanks Premium
CHEChemed$534.72$6.96B25.5217.67%Moderate BuyUnlock the CHE analyst price target with TipRanks PremiumDE:4TS vs CHEUnlock the CHE top-analyst price target with TipRanks Premium
HCSGHealthcare Services$24.52$1.65B16.2433.92%Moderate BuyUnlock the HCSG analyst price target with TipRanks PremiumDE:4TS vs HCSGUnlock the HCSG top-analyst price target with TipRanks Premium
PRVAPrivia Health Group$21.48$2.74B95.51-12.36%Strong BuyUnlock the PRVA analyst price target with TipRanks PremiumDE:4TS vs PRVAUnlock the PRVA top-analyst price target with TipRanks Premium

Performance Comparison

-60%-40%-20%0%20%40%60%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
DE:4TSTerveystalo Oy5.96-3.03-33.70%
TTALFTerveystalo Oy6.83-5.27-43.57%
SEMHFSiemens Healthineers AG47.69-7.21-13.13%
ADUSAddus Homecare125.546.555.50%
CHEChemed534.7296.3821.99%
HCSGHealthcare Services24.526.6437.14%
PRVAPrivia Health Group21.48-3.28-13.25%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts